Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Journal of Medicinal Chemistry
|
September 1, 1995
Synthesis and evaluation of 5-amino-5,6,7,8-tetrahydroquinolinones as potential agents for the treatment of Alzheimer's disease
D M Fink, G M Bores, R C Effland, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
Preclinical anxiolytic profiles of 7189 and 8319, novel non-competitive NMDA antagonists
R W Dunn, R Corbett, L L Martin, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
Preclinical anticonvulsant and neuroprotective profile of 8319, a non-competitive NMDA antagonist
S Fielding, J C Wilker, J Chernack, et al.
Journal of Medicinal Chemistry
|
September 16, 1994
Synthesis, resolution, and SAR of (+/-)-2-amino-N-methyl-alpha-(3-methyl-2-thienyl)benzeneethanamine++ + and related analogs as noncompetitive NMDA antagonists with neuroprotective properties
L L Martin, G E Lee, T B Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1996
Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine
G M Bores, F P Huger, W Petko, et al.
Journal of Medicinal Chemistry
|
July 10, 1992
3-[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]- 2,5,5-trimethyl-4-thiazolidinone: a new atypical antipsychotic agent for the treatment of schizophrenia
N J Hrib, J G Jurcak, D E Bregna, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1997
Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease
C P Smith, G M Bores, W Petko, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Journal of Medicinal Chemistry
|
September 1, 1995
Synthesis and evaluation of 5-amino-5,6,7,8-tetrahydroquinolinones as potential agents for the treatment of Alzheimer's disease
D M Fink, G M Bores, R C Effland, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
Preclinical anxiolytic profiles of 7189 and 8319, novel non-competitive NMDA antagonists
R W Dunn, R Corbett, L L Martin, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
Preclinical anticonvulsant and neuroprotective profile of 8319, a non-competitive NMDA antagonist
S Fielding, J C Wilker, J Chernack, et al.
Journal of Medicinal Chemistry
|
September 16, 1994
Synthesis, resolution, and SAR of (+/-)-2-amino-N-methyl-alpha-(3-methyl-2-thienyl)benzeneethanamine++ + and related analogs as noncompetitive NMDA antagonists with neuroprotective properties
L L Martin, G E Lee, T B Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1996
Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine
G M Bores, F P Huger, W Petko, et al.
Journal of Medicinal Chemistry
|
July 10, 1992
3-[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]- 2,5,5-trimethyl-4-thiazolidinone: a new atypical antipsychotic agent for the treatment of schizophrenia
N J Hrib, J G Jurcak, D E Bregna, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1997
Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease
C P Smith, G M Bores, W Petko, et al.
Page
of 2